Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen.

Morris CL, Siegel E, Barlogie B, Cottler-Fox M, Lin P, Fassas A, Zangari M, Anaissie E, Tricot G. Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol. 2003 Feb; 120(3):413-23.

View in: PubMed

subject areas

Adult
Age Factors
Aged
Antigens, CD34
Antineoplastic Agents
Cell Count
Female
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation
Humans
Leukocyte Count
Logistic Models
Male
Middle Aged
Multiple Myeloma
Multivariate Analysis
Neutrophils
Platelet Count
Retrospective Studies
Risk Factors
Stem Cell Factor
Treatment Outcome

authors with profiles

Maurizio Zangari
Guido Tricot
Michele Fox